Bioinspired Polysaccharide-Derived Zwitterionic Brush-like Copolymer as an Injectable Biolubricant for Arthritis
Qinyu Yue1,2, Lele Lei1,2, Ya Gu3
1State Key Laboratory of Solid Lubrication, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou, 730000, China.
Advanced Healthcare Materials
|April 4, 2022
Summary
New chitosan-graft-poly[2-(methacryloyloxy) ethyl phosphorylcholine] (PMPC) copolymers offer superior biocompatible biolubrication for arthritis treatment. These biomimetic lubricants demonstrate excellent friction reduction and protect joints from damage.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Biomedical Engineering
Background:
- Developing effective and biocompatible biolubricants is crucial for treating arthritis.
- Synovial joints provide a natural model for efficient lubrication.
Purpose of the Study:
- To design and synthesize novel brush-like Chitosan-g-PMPC copolymers.
- To evaluate their potential as biomimetic lubricants for arthritis treatment and artificial joint lubrication.
Main Methods:
- Facile one-step graft polymerization of chitosan with PMPC in an aqueous medium.
- Characterization of copolymer properties and lubrication performance on Ti6Al4V alloy.
- In vivo evaluation of anti-arthritic effects.
Main Results:
- Chitosan-g-PMPC copolymers exhibited a very low coefficient of friction (μ < 0.01) in water and biological fluids.
- Superior lubrication is attributed to PMPC hydration, copolymer adsorption, and hydrodynamic effects.
- In vivo studies showed reduced swelling and protection of bone and cartilage.
Conclusions:
- Chitosan-g-PMPC copolymers present a promising new class of biomimetic lubricants.
- Their facile synthesis, excellent lubrication, and biocompatibility make them suitable for arthritis treatment.
- This natural biopolymer-derived material offers potential for artificial joint lubrication.
